You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歌禮制藥-B(01672.HK):ASC09複方片和利托那韋獲武漢同濟醫院倫理委員會批准開展治療新型冠狀病毒感染臨牀研究
格隆匯 02-05 17:32

格隆匯2月5日丨歌禮制藥-B(01672.HK)公告,公司和華中科技大學同濟醫學院附屬同濟醫院開展科研合作。由寧琴教授團隊發起的"評價ASC09╱利托那韋複方片、利托那韋對於新型冠狀病毒感染的肺炎確診病例的療效及安全性的隨機、開放、對照的III期小樣本臨牀研究"已獲得華中科技大學同濟醫學院附屬同濟醫院倫理委員會批准。寧琴教授是中華醫學會感染學分會副主任委員,武漢同濟醫院感染性疾病研究所所長。公司將就該臨牀試驗的進展及時告知公眾。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account